Genetic Adaptation of Coxsackievirus B1 during Persistent Infection in Pancreatic Cells
Anni Honkimaa(University of Helsinki), Heikki Hyöty(Tampere University of Applied Sciences)
Cited by 13
Related Papers
A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models
|Diabetologia|2014|43
Early-life immunological and microbial differences between East African and North European children
|Communications Medicine|2026|0